Probability, predictors, and prognosis of posttransplantation glomerulonephritis

Journal of the American Society of Nephrology

Volumn 20, Issue 4, 2009, Pages 843-851

  Chailimpamontree, Worawon ^a   Dmitrienko, Svetlana ^a   Li, Guiyun ^a   Balshaw, Robert ^a   Magil, Alexander ^b   Shapiro, R Jean ^a   Landsberg, David ^a   Gill, John ^a   Keown, Paul A ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Gordon and Leslie Diamond Health Care Centre Vancouver Coastal Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CANADA; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY; SEX DIFFERENCE;

EID: 65249103360     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008050454     Document Type: Article

References (56)

1. Kirk A: Induction immunosuppression. Transplantation 82: 593-602, 2006
2. Yang H: Maintenance immunosuppression regimens: Conversion, minimization, withdrawal, and avoidance. Am J Kidney Dis 74: S37-S51, 2006
3. Gaston R: Current and evolving immunosuppressive regimens in kidney transplantation. Am J Kidney Dis 47: S3-S21, 2006
4. Zand M: Immunosuppression and immune monitoring after renal transplantation. Semin Dial 18: 511-519, 2005
5. US Renal Data System: Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
6. Australia and New Zealand Dialysis and Transplant Registry: ANZ- DATA Registry Report 2006, Adelaide, South Australia, Australia and New Zealand Dialysis and Transplant Registry, 2006
7. Canadian Organ Replacement Register: Treatment of End-Sage Organ Failure in Canada 1995 to 2004, Ottawa, Ontario, Canada, Canadian Institute for Health Information, 2006
8. Yao G, Albon E, Adi Y, Milford D, Bayliss S, Ready A, Raftery J, Taylor R: A systematic review and economic model of the clinical and cost- effectiveness of immunosuppressive therapy for renal transplantation in children. Health Technol Assess 10: 1-157, 2006
9. Winkelmayer W, Weinstein M, Mittleman M, Glynn R, Pliskin J: Health economic evaluations: The special case of end-stage renal disease treatment. Med Decis Making 22: 417-430, 2002
10. Parasuraman R, Yee J, Karthikeyan V, del Busto R: Infectious complications in renal transplant recipients. Adv Chronic Kidney Dis 13: 280-294, 2006
11. Van Dijk P: Renal replacement therapy in Europe. The results of a collaborative effort by the ERA-EDTA and six national or regional registries. Nephrol Dial Transplant 16: 1120-1129, 2001
12. Briganti E, Russ G, McNeil J, Atkins R, Chadban S: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347: 103-109, 2002
13. Hume D, Merrill J, Miller B, Thorn G: Experiences with renal homo- transplantation in the human: Report of nine cases. J Clin Invest 34: 327-382, 1955
14. Cameron J, Turner D: Recurrent glomerulonephritis in allografted kidneys. Clin Nephrol 7: 47-54, 1977
15. Hamburger J, Crosnier J, Noel L: Recurrent glomerulonephritis after renal transplantation. Annu Rev Med 29: 67-72, 1978
16. Morzycka M, Croker B, Siegler H, Tisher C: Evaluation of recurrent glomerulonephritis in kidney allografts. Am J Med 72: 588 -598, 1982
17. Schwarz A, Krause P, Offermann G, Keller F: Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine. Am J Kidney Dis 17: 524-531, 1991
18. Mathew T: Recurrence of disease following renal transplantation. Am J Kidney Dis 12: 85-96, 1988
19. Neumayer H, Kienbaum M, Graf S, Schreiber M, Mann J, Luft F: Prevalence and long-term outcome of glomerulonephritis in renal allografts. Am J Kidney Dis 22: 320-325, 1993
20. Hariharan S, Adams M, Brennan D, Davis C, First M, Johnson C, Ouseph R, Peddi V, Pelz C, Roza A, Vincenti F, George V: Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry (RADR). Transplantation 68: 635-641, 1999
21. Hariharan S, Peddi V, Savin V, Johnson C, First M, Roza A, Adams M: Recurrent and de novo renal diseases after renal transplantation: A report from the renal allograft disease registry. Am J Kidney Dis 31: 928-931, 1998
22. O'Meara Y, Green A, Carmody M: Recurrent glomerulonephritis in renal transplants: Fourteen years' experience. Nephrol Dial Transplant 4: 730-734, 1989
23. Andresdottir M, Hoitsma A, Assmann K, Koene R, Wetzels J: The impact of recurrent glomerulonephritis on graft survival in recipients of human histocompatibility leucocyte antigen-identical living related donor grafts. Transplantation 68: 623-627, 1999
24. Kotanko P, Pusey C, Levy J: Recurrent glomerulonephritis following renal transplantation. Transplantation 63: 1045-1052, 1997
25. Briggs J, Jones E: Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 14: 564-565, 1999
26. Odum J, Peh C, Clarkson A: Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9: 309 -312, 1994
27. Chadban S: Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 12: 394-402, 2001
28. Couser W: Recurrent glomerulonephritis in the renal allograft: An update of selected areas. Exp Clin Transplant 3: 283-288, 2005
29. Floege J: Recurrent glomerulonephritis following renal transplantation: An update. Nephrol Dial Transplant 18: 1260-1265, 2003
30. Hariharan S, Johnson C, Bresnahan B, Taranto S, McIntosh M, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342: 605-612, 2000
31. Choy B, Chan T, Lai K: Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 6: 2535-2542, 2006
32. Hariharan S: Long-term kidney transplant survival. Am J Kidney Dis 38: S44-S50, 2001
33. Odorico J, Knechtle S, Rayhill SC: The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 61: 228-234, 1996
34. Matas A: Recurrent disease after kidney transplantation: It is time to unite to address this problem! Am J Transplant 6: 2527-2528, 2006
35. Andresdottir M, Ajubi N, Croockewit S, Assmann K, Hibrands L, Wet- zels J: Recurrent focal glomerulosclerosis: Natural course and treatment with plasma exchange. Nephrol Dial Transplant 14: 2650-2656, 1999
36. Glassock R, Feldman D, Reynolds E, Dammin GJ, Merrill JP: Human renal isografts: A clinical and pathologic analysis. Medicine (Baltimore) 47: 411-454, 1968
37. Ibrahim H, Rogers T, Casingal V: Graft loss from recurrent glomerulo- nephritis is not increased with a rapid steroid discontinuation protocol. Transplantation 81: 214-219, 2006
38. Pardon A, Audard V, Caillard S, Moulin B, Desvaux D, Bentaarit B, Remy P, Sahali D, Roudot-Thoraval F, Lang P, Grimbert P: Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 21: 1053-1059, 2006
39. Daskalakis N, Winn M: Focal and segmental glomerulosclerosis: Varying biologic mechanisms underlie a final histopathologic end point. Semin Nephrol 26: 89 -94, 2006
40. Obeidová H, Merta M, Reiterová J, Maixnerová D, Stekrová J, Rysavá R, Tesar V: Genetic basis of nephrotic syndrome: Review. Prague Med Rep 107: 5-16, 2006
41. Ghiggeri G, Aucella F, Caridi G, Bisceglia L, Ghio L, Gigante M, Perfumo F, Carraro M, Gesualdo L: Posttransplant recurrence of proteinuria in a case of focal segmental glomerulosclerosis associated with WT1 mutation. Am J Transplant 6: 2208-2211, 2006
42. Löwik M, Groenen P, Pronk I, Lilien M, Goldschmeding R, Dijkman H, Levtchenko E, Monnens L, van den Heuvel L: Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int 72: 1198-1203, 2007
43. Plumb T, Greenberg A, Smith S, Butterly D, Pham T, Fields T, Howell D: Postinfectious glomerulonephritis in renal allograft recipients. Transplantation 82: 1224-1228, 2006
44. Pillet A, Guitard J, Mehrenberger M, Kamar N, Orfila C, Ribes D, Modesto A, Rostaing L: An unusual cause of acute renal failure in a kidney transplant recipient: Salmonella enteritidis post-infectious glomerulonephritis. Clin Nephrol 67: 321-324, 2007
45. Wenderfer S, Swinford R, Mauiyyedi S, Witte D, Braun M: Cytomegalovirus and recurrent idiopathic membranoproliferative glomerulonephritis type 1: Cause or consequence? Transplantation 83: 523-524, 2007
46. Morales J: Hepatitis C virus infection and renal disease after renal transplantation. Transplant Proc 36: 760-762, 2004
47. Egbuna O, Pavlakis M, Stillman I: Acute crescentic glomerulonephritis in a renal allograft: An unusual complication of fungal infection. Am J Kidney Dis 50: 468-470, 2007
48. Ozdemir B, Ozdemir F, Sezer S, Colak T, Haberal M: De novo glomerulonephritis in renal allografts with hepatitis C virus infection. Transplant Proc 38: 492-495, 2006
49. Cruzado J, Carrera M, Torras J, Grinyó J: Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 1: 171-178, 2001
50. Berthoux P, Laurent B, Cecillon S, Berthoux F: Membranoproliferative glomerulonephritis with subendothelial deposits (type 1) associated with hepatitis G virus infection in a renal transplant recipient. Am J Nephrol 19: 513-518, 1999
51. Hocker B, Knüppel T, Waldherr R, Schaefer F, Weber S, Tönshoff B: Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr Nephrol 21: 1476-1479, 2006
52. Letavernier E, Bruneval P, Mandet C, Van Huyen J, Peraldi M, Helal I, Noel L, Legendre C: High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol 2: 326-333, 2007
53. Little M, Dupont P, Campbell E, Dorman A, Walshe J: Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 69: 504-511, 2006
54. Swaminathan S, Lager D, Qian X, Stegall M, Larson T, Griffin M: Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant 21: 2607-2614, 2006
55. Gossmann J, Scheuermann E, Porubsky S, Kachel H, Geiger H, Hauser I: Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transpl Int 20: 558-562, 2007
56. Gallon L, Chhabra D: Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient. Am J Transplant 6: 3017-3021, 2006